Top brokers name 3 ASX shares to sell today

On Thursday I looked at a few shares that brokers had given buy ratings to this week.

Today I thought I would look at the unfortunate shares that have been given sell ratings.

Three that caught my eye are listed below. Here’s why they are rated as sells:


According to a note out of Deutsche Bank, its analysts have retained their sell rating and $6.70 price target on this testing services company’s shares. Despite expectations that the ALcontrol business it acquired in 2016 will add up to $10 million to EBITDA in FY 2019 and improve its Life Sciences margins, the broker isn’t in a hurry to change its rating after a disappointing full-year result release this week. I think Deutsche Bank has got this one right and would suggest investors wait for a better entry point.


A note out of Goldman Sachs reveals that it has retained its sell rating on the Australian stock exchange operator’s shares but raised its price target slightly to $47.00. Yesterday ASX Ltd announced the formation of Sympli with the intention of entering the national electronic property settlement market. The company will own a 50% stake in Sympli. While Goldman sees it as potentially positive to its long-term earnings, it expects the new company to be loss-making until FY 2021. While I wouldn’t be a seller of ASX Ltd shares if I owned them, I wouldn’t be a buyer unless they traded at a more attractive price.

Commonwealth Bank of Australia (ASX: CBA)

Analysts at Morgan Stanley have retained their underweight rating and $70.00 price target on the banking giant’s shares. The broker believes that slowing mortgage growth could weigh on the banking sector. Especially given that tighter lending standards means the banks will have to fight harder to win low-risk loans. With the bank’s shares now below Morgan Stanley’s price target, I would class Commonwealth Bank as more of a buy than a sell.

While those shares may be classed as sells, I think these top shares are strong buys right now.

3 Growth Shares To Buy In June

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of ASX Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.